The test strip comprises a porous, hydrophilic matrix having a sample receiving surface adapted to receive the whole blood sample on one side of the matrix and a testing surface from which diffuse reflected light is measurable from the other side of the matrix, wherein the testing surface is opposite to the sample receiving surface. The matrix is substantially reflective in the absence of applied sample, and contains openings of a size sufficient to allow the flow of at least a portion of the blood sample through the matrix from the sample-receiving surface to the testing surface. The matrix comprises glucose oxidase, peroxidase, and a dye precursor for chemically reacting with glucose to cre ate a change in reflectance in the presence of optically visible hemoglobin observable from the testing surface which change is indicative of the concentration of glu cose present in the sample. The dye precursor com prises 3-dimethylaminobenzoic acid and 3-methyl-2-benzothiazolinone hydrazone hydrochloride. 
--------------------------

BACKGROUND OF THE INVENTION
The quantification of chemical and biochemical com ponents in colored aqueous fluids, in particular colored biological fluids such as whole blood and urine and biological fluid derivatives such as blood serum and blood plasma, is of ever-increasing importance. Impor tant applications exist in medical diagnosis and treat ment and in the quantification of exposure to therapeu tic drugs, intoxicants, hazardous chemicals and the like. In some instances, the amounts of materials being deter mined are either so miniscule-in the range of a micro gram or less per deciliter-or so difficult to precisely determine that the apparatus employed is complicated and useful only to skilled laboratory personnel. In this case the results are generally not available for some hours or days after sampling. In other instances, there is often an emphasis on the ability of lay operators to perform the test routinely, quickly and reproducibly outside a laboratory setting with rapid or immediate information display. One common medical test is the 2 measurement of blood glucose levels by diabetics. Cur rent teaching counsels diabetic patients to measure their blood glucose level from two to seven times a day de pending on the nature and severity of their individual cases. Based on the observed pattern in the measured glucose levels, the patient and physician together make adjustments in diet, exercise and insulin intake to better manage the disease. Clearly, this information should be available to the patient immediately.
Currently a method widely used in the United States employs a test article of the type described in U.S. Pat. NO. 3,298,789 issued Jan. 17, 1967 to Mast. In this method a sample of fresh, whole blood (typically 20-40 ul) is placed on an ethylcellulose-coated reagent pad containing an enzyme system having glucose oxidase and peroxidase activity. The enzyme system reacts with glucose and releases hydrogen peroxide. The pad also contains an indicator which reacts with the hydrogen peroxide in the presence of peroxidase to give a color proportional in intensity to the sample's glucose level.
Another popular blood glucose test method employs similar chemistry but in place of the ethylcellulose coated pad employs a water-resistant film through which the enzymes and indicator are dispersed. This type of system is disclosed in U.S. Pat. No. 3,630,957 issued Dec. 28, 1971 to Rey et al.
In both cases the sample is allowed to remain in contact with the reagent pad for a specified time (typi cally one minute). Then in the first case the blood san ple is washed off with a stream of water while in the second case it is wiped off the film. The reagent pad or film is then blotted dry and evaluated. The evaluation is made either by comparing color generated with a color chart or by placing the pad or film in a diffuse reflec tance instrument to read a color intensity value.
While the above methods have been used in glucose monitoring for years, they do have certain limitations. The sample size required is rather large for afinger stick test and is difficult to achieve for some people whose capillary blood does not express readily.
In addition, these methods share a limitation with other simple lay-operator colorimetric determinations in that their result is based on an absolute color reading which is in turn related to the absolute extent of reac tion between the sample and the test reagents. The fact that the sample must be washed or wiped off the reagent pad after the timed reaction interval requires that the user be ready at the end of the timed interval and wipe or apply a wash stream at the required time. The fact that the reaction is stopped by removing the sample leads to some uncertainty in the result, especially in the hands of the home user. Overwashing can give low results and underwashing can give high results.
Another problem that often exists in simple lay-oper ator colorimetric determinations is the necessity for initiating a timing sequence when blood is applied to a reagent pad. A user will typically have conducted a finger stick to obtain a blood sample and will then be required to simultaneously apply the blood from the finger to a reagent pad while initiating a timing circuit with his or her other hand, thereby requiring the use of both hands simultaneously. This is particularly difficult since it is often necessary to insure that the timing cir cuit is started only when blood is applied to the reagent pad. All of the prior art methods require additional manipulations or additional circuitry to achieve this result. Accordingly, simplification of this aspect of re flectance reading instruments is desirable. 3,298,789 an ethyl cellulose membrane prevents red blood cells from entering the reagent pad. Similarly, the water-resistant film of U.S. Pat. No. 3,630,957 prevents red blood cells from entering the pad. In both cases the rinse or wipe also acts to remove these potentially inter fering red blood cells prior to measurement.
Accordingly, there remains a need for a system of detecting analytes in colored liquids, such as blood, that does not require removal of excess liquid from a reflec tance strip from which a reflectance reading is being obtained.
SUMMARY OF THE INVENTION
Novel methods, compositions and apparatus are pro vided for diagnostic assays comprising a hydrophilic porous matrix containing a signal producing system and a reflectance measuring apparatus which is activated upon a change in reflectance of the matrix when fluid penetrates the matrix. The method comprises adding the sample, typically whole blood, to the matrix which filters out large particles, such as red blood cells, typi cally with the matrix present in the apparatus. The signal-producing system produces a product which further changes the reflectance of the matrix, which change can be related to the presence of an analyte in a sample.
Exemplary of the diagnostic assay system is the deter mination of glucose in the whole blood, where the de termination is made without interference from the blood and without a complicated protocol subject to SeeTOT. Brief Description of the Drawings The present invention can be more readily under stood by reference to the following detailed description when read in conjunction with the attached drawings, The Reagent Element The subject invention provides an improved rapid and simple methodology employing reliable and easy to operate apparatus for the determination of analytes such as glucose, particularly involving an enzyme substrate which results in the production of hydrogen peroxide as an enzyme product. The method involves applying to a porous matrix a small volume of whole blood, sufficient to saturate the matrix. It is to be noted that the present system is capable of determining glucose levels from optical readings of whole blood samples. Separation of plasma from blood in the sample is unnecessary, and the present invention avoids the requirement of this step. In addition, this system is capable of performing accurate readings as long as only a small volume saturates the matrix of the test strip. Above this threshold, the read ing is volume independent.
Bound to the matrix are one or more reagents of a signal producing system, which results in the produc tion of a product resulting in an initial change in the amount of reflectance of the matrix. The matrix is typi cally present in a reflectance-measuring apparatus when blood is applied. The liquid sample penetrates the ma trix, resulting in an initial change in reflectance at the measurement surface. A reading is then taken at one or more times after thee initial change in reflectance to relate the further change in reflectance at the measure ment surface or in the matrix as a result of formation of the reaction product to the amount of analyte in the sample.
For measurements in blood, particularly glucose measurements, whole blood is typically used as the assay medium. The matrix contains an oxidase enzyme which produces hydrogen peroxide. Also contained in the matrix will be a second enzyme, particularly a per oxidase, and a dye system which produces a light absorbing product in conjunction with the peroxidase. The light-absorbing product changes the reflectance signal of the matrix system. With whole blood, readings are taken at two different wavelengths, with the reading at one wavelength used to subtract out background interference caused by hematocrit, blood oxygenation, and other variables which may affect the result. Thus, the present invention is capable of analyzing samples of whole blood.
A reagent elements employed which comprises the matrix and the members of the signal producing system contained within the matrix. The reagent element may include other components for particular applications. The method requires applying a small volume of blood, which typically has not been subject to prior treatment (other than optional treatment with an anticoagulant), to the matrix. Timing of the measurement is activated or initialized by the apparatus' automatically detecting a change in reflectance of the matrix when fluid pene trates the matrix. The change in reflectance over a pre determined time period as a result of formation of reac tion product is then related to the amount of analyte in a sample. The intensity of the light source used to ana lyze the sample is, of course, also carefully monitored and regulated, to insure the repeatability of the mea Seneat.
The first component of the present invention to be considered is a reagent element, conveniently in the 5,426,032 5 shape of a pad, comprising an inert porous matrix and the component or components of a signal-producing system, which system is capable of reacting with an analyte to produce a light-absorbing reaction product, impregnated into the pores of the porous matrix. The signal-producing system does not significantly impede the flow of liquid through the matrix.
In order to assist in reading reflectance, it is preferred that the matrix have at least one side which is substan tially smooth and flat. Typically, the matrix will be formed into a thin sheet with at least one smooth, flat side. In use, the liquid sample being analyzed is applied to one side of the sheet whereby any assay compound present passes through the reagent element by means of capillary, wicking, gravity flow and/or diffusion ac tions. The components of the signal producing system present in the matrix will react to give a light absorbing reaction product. Incident light impinges upon the rea gent element at a location other than the location to which the sample is applied. Light is thus reflected from the surface of the element as diffuse reflected light. This diffuse light is collected and measured, for example by the detector of a reflectance spectrophotometer. The amount of reflected light will be related to the amount of analyte in the sample, usually being an inverse func tion of the amount of analyte in the sample.
The Matrix
Each of the components necessary for producing the reagent element will be described in turn. The first component is the matrix itself.
The matrix will be a hydrophilic porous matrix to which reagents may be covalently or noncovalently bound. The matrix will allow for the flow of an aqueous medium through the matrix. It will also allow for bind ing of protein compositions to the matrix without signif. icantly adversely affecting the biological activity of the protein, e.g., enzymatic activity of an enzyme. To the extent that proteins are to be covalently bound, the matrix will have active sites for covalent bonding or may be activated by means known to the art. The com position of the matrix will be reflective and will be of sufficient thickness to permit the formation of a light absorbing dye in the void volume or on the surface to substantially affect the reflectance from the matrix. The matrix may be of a uniform composition or a coating on a substrate providing the necessary structure and physi cal properties.
The matrix will usually,not deform on wetting, thus retaining its original conformation and size. The matrix will have a defined absorbance, so that the volume which is absorbed can be calibrated within reasonable limits, variations usually being maintained below about 50% preferably not greater than 10%. The matrix will have sufficient wet strength to allow for routine manu facture. The matrix will permit non-covalently bound reagents to be relatively uniformly distributed on the surface of the matrix.
As exemplary of matrix surfaces are polyamides, particularly with samples involving whole blood. The polyamides are conveniently condensation polymers of monomers of from 4 to 8 carbon atoms, where the mon omers are lactams or combinations of diamines and di-carboxylic acids. Other polymeric compositions hav ing comparable properties may also find use. The poly amide compositions may be modified to introduce other functional groups which provide for charged struc tures, so that the surfaces of the matrix may be neutral, When used with whole blood, the porous matrix preferably has pores with an average diameter in the range of from about 0.1 to 2.0 um, more preferably from about 0.6 to 1.0 pum. When the porous matrix contains pores having an average diameter of about 0.8 un, the sample of blood will not cause a chromatographic ef fect. That is, the blood sample will not seek out the edges of the circular matrix. Rather, the blood remains seated within all the pores of the matrix and provides for a uniform readability of the entire matrix. In addi tion, this pore size maximizes the non-blotting effect of the blood. That is, the pore size is both adequately filled, but not overfilled, so that the hematocrit level of blood will not cause the sample to require blotting prior to reading of the sample. Also, it has been found that pores of this size are optimal when shelf-life and stability are taken into consideration.
A preferred manner of preparing the porous material is to cast the hydrophilic polymer onto a core of non woven fibers. The core fibers can be any fibrous mate rial that produce the described integrity and strength, such as polyesters and polyamides. The reagent that will form the light-absorbing reaction product, which is discussed later in detail, is present within the pores of the matrix but does not block the matrix so that the liquid portion of the assay medium, e.g. blood, being analyzed can flow through the pores of the matrix, while particles, such as erythrocytes, are held at the surface.
The matrix is substantially reflective so that it gives a diffuse reflectance without the use of a reflective back ing. Preferably at least 25%, more preferably at least 50%, of the incident-light applied to the matrix is re flected and emitted as diffuse reflectance. A matrix of less than about 0.5 mm thickness is usually employed, with from about 0.01 mm to about 0.3 mm being pre ferred. A thickness of from about 0.1 mm to about 0.2 mm is most preferred, particularly for a nylon matrix.
Typically, the matrix will be attached to a holder in order to give it physical form and rigidity, although this may not be necessary. FIG. 1 shows one embodiment of the invention in which there is a strip 10 having a thin hydrophilic matrix pad 11 is positioned at one end of a plastic holder or handle 12 by means of an adhesive 13 which directly and firmly attaches the reagent pad 11 to the handle 12. A hole 14 is present in the plastic holder 12 in the area to which reagent pad 11 is attached so that sample can be applied to one side of the reagent pad and light reflected from the other side.
A liquid sample to be tested is applied to pad 11. Generally, with blood being exemplary of a sample being tested, the reagent pad will be on the order of about 10 mm2 to 100 mm2 in surface area, especially 10 mm2 to 50 mm2 in area (or having a diameter of about 2 mm to about 10 mm), which is normally a volume that 5-10 microliters of sample will more than saturate. Of course, once saturation is reached at above the thresh old of about 5-10 microliters, no other requirement of blood amount is necessary.
Diffuse reflectance measurements in the prior art have typically been taken using a reflective backing attached to or placed behind the matrix. No such back ing is needed or will normally be present during the 5,426,032 7 practice of the present invention, either as part of the reagent element or the reflectance apparatus.
As can be seen from FIG. 1, the support holds rea gent pad 11 so that a sample can be applied to one side of the reagent pad 11 while light reflectance is measured from the side of the reagent pad 11 opposite the location where sample is applied. FIG.2 shows a system in which the reagent is applied to the side with the hole 14 in the backing handle 12 while light is reflected and measured on the other side of the reagent pad 11. Other structures than the one depicted may be employed. The pad 11 may take vari ous shapes and forms, subject to the limitations pro vided herein. The pad 11 will be accessible on at least one surface and usually two surfaces.
The hydrophilic layer (reagent element) may be at tached to the support by any convenient means, e.g., a holder, clamp or adhesives; however, in the preferred method it is bonded to the backing. The bonding can be done with any non-reactive adhesive, by a thermal method in which the backing surface is melted enough to entrap some of the material used for the hydrophilic layer, or by microwave or ultrasonic bonding methods which likewise fuse the hydrophilic sample pads to the backing. It is important that the bonding be such as to not itself interfere substantially with the diffuse reflec tance measurements or the reaction being measured, although this is unlikely to occur as no adhesive need be present at the location where the reading is taken. For example, an adhesive 13 can be applied to the backing strip 12 followed first by punching hole 14 into the combined strip and adhesive and then applying reagent pad 11 to the adhesive in the vicinity of hole 14 so that the peripheral portion of the reagent pad attaches to the backing strip.
The Chemical Reagents Any signal producing system may be employed that is capable of reacting with the analyte in the sample to produce (either directly or indirectly) a compound that is characteristically absorptive at a wavelength other than a wavelength at which the assay medium substan tially absorbs.
Polyanide matrices are particularly useful for carry ing out reactions in which a substrate (analyte) reacts with an oxygen-utilizing oxidase enzyme in such a man ner that a product is produced that further reacts with a dye intermediate to either directly or indirectly form a dye which absorbs in a predetermined wavelength range. For example, an oxidase enzyme can oxidize a substrate and produce hydrogen peroxide as a reaction product. The Analysis Method The analysis method of this invention relies on a change in absorbance, as measured by diffuse reflec tance, which is dependent upon the amount of analyte present in a sample being tested. This change may be determined by measuring the change in the absorbance of the test sample between two or more points in time.
The first step of the assay to be considered will be application of the sample to the matrix. In practice, an analysis could be carried out as follows: First a sample of aqueous fluid containing an analyte is obtained. Blood may be obtained by a finger stick, for example.
An excess over threshold matrix saturation in the area where reflectance will be measured (i.e., about 5-10 microliters) of this fluid is applied to the reagent ele ment or elements of the test device. Simultaneous start ing of a timer is not required (as is commonly required in the prior art), as will become clear below, due to the initialization procedure practiced by the present inven tion. Excess fluid can be removed, such as by light blotting, but such removal is also not required. The test device is typically mounted in an instrument for reading light absorbance, e.g., color intensity by reflectance, prior to application of the sample. Absorbance is mea sured at certain points in time after application of the sample. Absorbance refers in this application not only to light within the visual wavelength range but also outside the visual wavelength range, such as infrared and ultraviolet radiation. From these measurements of absorbance a rate of color development can be cali brated in terms of analyte level.
The Light source 5 and/or detector 6 can be adapted to generate or respond to a particular wavelength light, if desired. The output of detector 6 is passed to amplifier 7, for example, a linear integrated circuit which con verts the phototransistor current to a voltage. The out put of amplifier 7 can be fed to track and hold circuit 8. This is a combination linear/digital integrated circuit which tracks or follows the analog voltage from ampli fier 7 and, upon command from microprocessor 20, locks or holds the voltage at its level at that time.
Analog-to-digital converter 19 takes the analog volt age from track and hold circuit 8 and converts it to, for example, a twelve-bit binary digital number upon com mand of microprocessor 20. Microprocessor 20 can be a digital integrated circuit. It serves the following control functions: 1) timing for the entire system; 2) reading of the output of analog/digital converter 19; 3) together with program and data memory 21, storing data corre sponding to the reflectance measured at specified time intervals; 4) calculating analyte levels from the stored reflectances; and 5) outputting analyte concentration data to display 22. Memory 21 can be a digital inte grated circuit which stores data and the microprocessor operating program. Reporting device 22 can take vari ous hard copy and soft copy forms. Usually it is a visual display, such as a liquid crystal (LCD) or LED display, but it can also be a tape printer, audible signal, or the like. The instrument also can include a start-stop switch and can provide an audible or visible time output to indicate times for applying samples, taking readings etc., if desired.
Reflectance Switching
In the present invention, the reflectance circuit itself can be used to initiate timing by measuring a drop in reflectance that occurs when the aqueous portion of the suspension solution applied to the reagent pad (e.g., blood) migrates to the surface at which reflectance is being measured. Typically, the measuring device is turned on in a "ready' mode in which reflectance read ings are automatically made at closely spaced intervals (typically about 0.2 seconds) from the typically off white, substantially dry, unreacted reagent strip. The initial measurement is typically made prior to penetra tion of the matrix by fluid being analyzed but can be made after the fluid has been applied to a location on the reagent element other than where reflectance is being measured. The reflectance value is evaluated by the microprocessor, typically by storing successive values in memory and then comparing each value with the initial unreacted value. When the aqueous solution pen etrates the reagent matrix, the drop in reflectance sig nals the start of the measuring time interval. Drops in reflectance of 5-50% can be used to initiate timing, typically a drop of about 10%. In this simple way there is exact synchronization of assay medium reaching the surface from which measurements are taken and initia Although the total systems described in this applica tion are particularly directed to the use of polyamide matrices and particularly to the use of such matrices in determining the concentration of various sugars, such as glucose, and other materials of biological origin, there is no need to limit the reflectance switching aspect of the invention to such matrices. For example, the matrix used with reflectance switching may be formed from any water-insoluble hydrophilic material and any other type of reflectance assay.
Particularly Application to Glucose Assay A particular example with regard to detecting glu cose in the presence of red blood cells will now be given in order that greater detail and particular advantage can be pointed out. Although this represents a preferred embodiment of the present invention, the invention is not limited to the detection of glucose in blood.
The use of polyamide surfaces to form the reagent element provides a number of desirable characteristics in the present invention. These are that the reagent element is hydrophilic (i.e., takes up reagent and sample readily), does not deform on wetting (so as to provide a flat surface for reflectance reading), is compatible with enzymes (in order to impart good shelf stability), takes up a limited sample volume per unit volume of mem brane (necessary in order to demonstrate an extended dynamic range of measurements), and shows sufficient wet strength to allow for routine manufacture.
In a typical configuration, the method is carrier out using an apparatus consisting of a plastic holder and the reagent element (the matrix having the signal producing system impregnated therein.) The preferred matrix for use in preparing the reagent element is a nylon microfil tration membrane, particularly membranes made from nylon-66 cast on a core of non-woven polyester fibers. Numerous nylon microfiltration membranes of this class are produced commercially by the Pall Ultrafine Filtra tion Corporation, having average pore sizes from 0.1 to 3.0 microns. These materials shown mechanical strength and flexibility, dimensional stability upon expo sure to water, and rapid wetting.
Many variations in specific chemical structure of the nylon are possible. These include unfunctionalized ny lon-66 with charged end groups (sold under the trade mark ULTRAPORE by Pall Ultrafine Filtration Cor poration, "Pall'). Positive charges predominate below pH 6 while negative charges predominate above pH 6. In other membranes the nylon is functionalized before the membrane is formed to give membranes with differ ent properties. Nylons functionalized with carboxy groups are negatively charged over a wide pH range (sold as CARBOXYDYNE by Pall). Nylons can also be functionalized with a high density of positively charged groups on its surface, typically quaternary amine groups, so that they display little variation in charge over a wide pH range (sold as POSIDYNE by Pall). Such materials are particularly well suited for the prac tice of the present invention.
It has been found that keeping the pH of the solution below 4.8 will help stabilize the enzymes in solution.
The most efficient level of stability has been found at pH 4.0. This results in shelf life at room temperature of 2-18 months. Consequently, a strip with positively charged ions is most desirable.
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It is also possible to use membranes having reactive functional groups designed for covalent immobilization of proteins (sold as BIODYNE IMMUNO AFFINITY membranes by Pall). Such materials can be used to covalently attach proteins, e.g. enzymes, used as rea gents. Although all of these materials are usable, nylon having a high density of positively charged groups on its surface provide the best stability of reagents when formulated into a dry reagent pad. Unfunctionalized nylon gives the next best stability with the carboxylated nylons next best.
Desirable results can be obtained with pore sizes ranging from about 0.2-2.0 um, preferably about 0.5-1.2 pm, and most preferably about 0.8 um, when used with whole blood.
The form of the handle on which the reagent element is assembled is relatively unimportant as long as the handle allows access to one side of the reagent element by sample and to the other side of the reagent element by incident light whose reflectance is being measured. The handle also aids in inserting the reagent element into the absorbance measuring device so that it registers with the optical system. One example of a suitable han dle is a mylar or other plastic strip to which a transfer adhesive such as 3M 465 or Y9460 transfer adhesive has been applied. A hole is punched into the plastic through the transfer adhesive. A reagent element, typically in the form of a thin pad, either containing reagents or to which reagents will later be added, is then applied to the handle by means of the transfer adhesive so that it is firmly attached to the handle in the area surrounding the hole that has been punched through the handle and the transfer adhesive.
Such a device is illustrated in FIG. 1 , which shows a strip 10 having a reagent pad 11 attached to a Mylar handle 12 by means of adhesive 13. Hole 14 allows access of the sample or incident light to one side of reagent pad 11 while access to the other side of the reagent pad is unrestricted. All dimensions of the rea gent pad and handle can be selected so that the reagent pad fits securely into a reflectance-reading instrumentin proximal location to a light source and a reflected-light detector. Generally, dimensions of the hole are in the range of about 2-10 mm diameter, and that of the width of the handle about 15 mm. A 5 mm diameter hole 14 in the reagent strip shown in FIG. 1 works quite satisfac torily. Naturally, there is no particular limit on the minimum diameter of such a hole, although diameters of at least 2 mm are preferred for ease of manufacture, sample application, and light reflectance reading.
As further seen in FIGS. 3 and 4, the strip 10 can be optimally guided into a slot 50 on scanning machine 60. This is accomplished by placing a notch 15 in the strip 10 at about the midpoint of the top of strip 10. In so doing, the strip 10, when guided through sides 55 of slot 50, will arrive repeatably at the same location, to assure high assurance in test results. Such repeatability is ac complished by moving the notch 15 against post 65. The strip 10 will pivot around the post 65 at the notch 15, so that the edges 16 of the strip will fit within the sides 55 of the slot 50. This, of course, also repeatably aligns the hole 14 over the test center 80 comprising multiple LEDs 5 in the scanning machine 60. This insures that the hole 14 containing a blood sample will have uniform dosage of incident light for analysis.
Although a number of dyes could be used as indica tors, the choice will depend upon the nature of the sample. It is necessary to select a dye having an absor bance at a wavelength different from the wavelength at which red blood cells absorb light, with whole blood as the assay medium, or other contaminants in the solution being analyzed with other assay media. The MBTH DMAB dye couple (3-methyl-2-benzothiazolinone hy drazone hydrochloride and 3-dimethylaminobenzoic acid), although being previously described as suitable for color development for peroxidase labels in enzyme immunoassays, has never been used in a commercial glucose measuring reagent. This dye couple gives greater dynamic range and shows improved enzymatic stability as compared to traditional dyes used for glu cose measurement, such as benzidine derivatives. This enzymatic stability also makes the MBTH-DMAB dye couple especially desirable in order to insure longer shelf life of the test strips. Furthermore, the MBTH DMAB dye couple is not carcinogenic, a characteristic of most benzidine derivatives.
Another dye couple that can be used in the measure ment of glucose is the AAP-CTA (4-aminoantipyrene and chromotropic acid) couple. Although this couple does not provide as broad a dynamic range as MBTH DMAB, it is stable and suitable for use in the practice of the present invention when measuring glucose. Again, the AAP-CTA dye couple provides an expanded dy namic range and greater enzymatic activity stability than the more widely used benzidine dyes.
The use of the MBTH-DMAB couple allows for correction of hematocrit and degree of oxygenation of blood with a single correction factor. The more typi cally used benzidine dyes do not permit such a correc tion. The MBTH-DMAB dye forms a chromophore that absorbs at approximately 635 nm but not to any significant extent at 700 nm. Slight variations in measur ing wavelengths (-tt about 10 nm) are permitted. At 700 nm both hematocrit and degree of oxygenation can be measured by measuring blood color. Furthermore, light emitting diodes (LED) are commercially available for both 635 nm and 700 nm measurements, thereby simpli fying mass-production of a device. By using the pre ferred membrane pore size described above and the subject reagent formulation, both hematocrit and oxy genation behavior can be corrected by measuring at the single 700 nm wavelength.
Two additional conditions were found to provide particular stability and long shelf life for a glucose ox idase/peroxidase formulation on a polyamide matrix. Storage is enhanced at a pH in the range of 3.8 to 5.0 preferably about 3.8 to 4.3, most preferably about 4.0. Similarly, unexpectedly good storage and stability was found with mixture of a concentrated buffer system to the the reagents found in the matrix. The most effective buffer was found to be a 10% weight citrate buffer, with concentrations from about 5-15% being effective. These are weight/volume percentages of the solution in which the reagents are applied to the matrix. Other buffers can be used on the same molar basis. Greatest stability was achieved using a low pH, preferably about pH 4, an MBTH-DMAB dye system, and a high en zyme concentration of approximately 500-1000 M/ml of application solution. As previously indicated, such strips prepared using these parameters result in shelflife of about 12-18 months.
In preparing the MBTH-DMAB reagent and the enzyme system that forms the remainder of the signal producing system, it is not necessary to maintain exact volumes and ratios although the suggested values below give good results. Reagents are readily absorbed by the 5,426,032 13 matrix pad when the glucose oxidase is present in a solution at about 27-54% by volume, the peroxidase is present at a concentration of about 2.7-5.4 mg/ml, MBTH is present at a concentration of about 4-8 mg/ml, and DMAB is present at a concentration of 5 about 8-16 mg/ml. The DMAB-MBTH weight ratio is preferably maintained in the range of 1:1 to 4:1, prefera bly about 1.5:1 to 2.5:1, most preferably about 2:1.
The basic manufacturing techniques for the reagent element are, once established, straightforward. The membrane itself is strong and stable, particularly when a nylon membrane of the preferred embodiment is se lected. Only two solutions are necessary for applying reagent, and these solutions are both readily formulated and stable. The first generally contains the dye compo nents and the second generally contains the enzymes. When using the MBTH-DMAB dye couple, for exam ple, the individual dyes are dissolved in an aqueous organic solvent, typically a 1:1 mixture of acetonitrile and water. The matrix is dipped into the solution, excess liquid is removed by blotting, and the matrix is then dried, typically at 50 C-60C. for 10-20 minutes. The matrix containing the dyes is then dipped into an aque ous solution containing the enzymes. A typical formula tion would contain the peroxidase and glucose oxidase enzymes as well as any desired buffer, preservative, 6 ml water, 10 mg EDTA, disodium salt, 200 mg Sigma Poly PepTM, low viscosity, 0.668 g sodium citrate, 0.523 g citric acid,
2.0 ml 6 wt % GAF Gantrez TM AN-139 dissolved in water 30 mg horseradish peroxidase, 100 units/mg, and 3.0 ml glucose oxidase, 2000 units/ml. Stir until all solids are dissolved and pour onto a glass plate or other flat surface. Dip a piece of membrane previously impregnated with dyes, blot off excess liq uid, and dry at 56' C. for 15 minutes.
The electronic apparatus used to make the reflec tance readings minimally contains a light source, a re flected light detector, an:amplifier, an analog to digital converter, a microprocessor-with memory and pro gram, and a display device, as seen in FIG. 2 .
The light source typically consists of a light emitting diode (LED). Although it is possible to use a polychro matic light source and a light detector capable of mea suring at two different wavelengths, a preferred appara tus would contain two LED sources or a single diode capable of emitting two distinct wavelengths of light.
Commercially available LEDs producing the wave Although other methods of taking measurements are feasible, the following method has provided the desired results. Readings are taken by the photodetector at specified intervals after timing is initiated. The 635 nm. LED is powered only during a brief measuring time span that begins approximately 20 seconds after the start time as indicated by the previously described re flectance switching system. If this reading indicates that a high level of glucose is present in the sample, a 30 second reading is taken and used in the final calculation in order to improve accuracy. Typically, high levels are considered to begin at about 250 mg/dl. The back ground is corrected with a 700 nm reading taken about 15 seconds after the start of the measurement period. The reading from the photodetector is integrated over the interval while the appropriate LED is activated, which is typically less than one second. The raw reflec tance readings are then used for calculations performed by the microprocessor after the signal has been ampli fied and converted to a digital signal. Numerous micro processors can be used to carry out the calculation. An AIM65 single-board microcomputer manufactured by Rockwell International has proven to be satisfactory.
The present methods and apparatuses allow a very simple procedure with minimum operational steps on the part of the user. In use, the reagent strip 10 is placed in the detector so that the hole 14 in the strip 10 regis ters with the optics of the detecting system. The above described notch 15/post 65 system, as seen in FIGS. 4 and 5 works nicely to accomplish such alignment. A removable cap or other cover 90 is placed over the optics and strip to shield the assembly from ambient light. This is done to enhance reading of the strip 10. While the initilization process can begin in light, direct sunlight or high intensity room light tends to inhibit results. The cap 90 insures that direct light does not hit the reagent strip 10. The cap 90 need not be light-tight, only enough to protect the strip 10 from direct light.
The measurement sequence is then initiated by press ing a button on the measuring apparatus that activates the microcomputer to take a measurement of reflected light from the unreactedreagent pad, called an Rdy reading. The cap 90 is then removed and a drop of blood is applied to the reagent strip 10, typically while the reagent strip 10 is registered with the optics and the reading device. It is preferred that the reagent strip be left in register with the optics in order to minimize handling. The cap 90 is then closed.
The instrument is capable of-sensing the application of blood or other sample by a decrease in the reflec tance when the sample passes through the matrix and reflected light is measured on the opposite side. The decrease in reflectance initiates a timing sequence which is described in detail at other locations in this specification. The cap 90 should be replaced within 15 seconds of sample application, although this time may vary depending on the type of sample being measured.
Results are typically displayed at approximately 30 seconds after blood application when a blood glucose sample is being measured, although a 20 second reaction is permissible for glucose samples having a concentra 5,426,032 15 tion of glucose of less than 250 mg/dl. If other samples are being measured, suitable times for displaying the result may differ and can be readily determined from the characteristics of the reagent/sample selected.
A particularly accurate evaluation of glucose level (or any other analyte being measured) can be made using the background current, i.e., the current from the photo detector with power on but with no light re flected from the reagent pad, in order to make a back ground correction. It has been demonstrated that over a 2-3 month period that this value does not change for a particular instrument prepared according to the pre ferred embodiments of this specification, and it is possi ble to program this background reading into the com puter memory as a constant.
With a slight modification of the procedure, how ever, this value can be measured (or normalized) with each analysis for more accurate results. Each LED is turned on prior to placement of the blood sample on the reagent strip 10 but with the reagent strip 10 in place. A reflectance value of the strip 10 is then measured, with the reagent strip 10 in place and the light protective cap 90 closed. If this measurement is different than the origi nal measurement of the reflectance value, power to the LED is increased so that the reflectance will be the same. This insures that the measurement of blood glu cose content is being made on the same repeatable scale for each blood glucose reading.
The reason for instituting this method is twofold. First, the intensity of light emitting diodes will vary greatly from LED to LED, even when all the measur ing LEDs are new. Second, the LED efficiency will vary with both temperature and the life of the LED. With this method, results are repeatable on the same scale.
The raw data necessary for calculating a result in a glucose assay are a background current reported as background reflectance, Rb, as described above; a read ing of the unreacted test strip, Rd, which is about 95% opaque to light and is also described above; and an end point measurement. Using the preferred embodiments described herein, the end point is not particularly stable and must be precisely timed from the initial application of blood. However, the meter as described herein per forms this timing automatically. For glucose concentra tions below 250 mg/dl., a suitably stable end point is reached in 20 seconds, and a final reflectance, R20, is taken. For glucose concentrations up to 450 mg/dl., a 30-second reflectance reading, R30, is adequate. Al though the system described herein displays good dif ferentiation up to 800 mg/dl of glucose, the measure ment is somewhat noisy and inaccurate above 450 mg/dl., although not so great as to cause a significant problem. Longer reaction times should provide more suitable readings for the higher levels of glucose con centration.
The 700 nm reflectance reading for the dual wave length measurement is typically taken at 15 seconds (R15). By this time blood will have completely saturated the reagent pad. Beyond 15 seconds the dye reaction continues to take place and is sensed, to a small part, by a 700 nm reading. Accordingly, since dye absorption by the 700 nm signal is a disadvantage, readings beyond 15 seconds are ignored in the calculations. The coefficients for these polynomials are listed in Table 1 . The single chemical species being measured in the preferred embodiments is the MBTH-DMAB inamine dye and the complex matrix being analyzed is whole blood distributed on a 0.8. Posidyne TM membrane. A review entitled "Application of Near Infra Red Spec trophotometry to the Nondestructive Analysis of Foods: A Review of Experimental Results", CRC Criti cal Reviews in Food Science and Nutrition, 18(3) 203-30 (1983) , describes the use of instruments based on the measurement of an optical density difference AOD (Aa-AB) where ODAais the optical density of the wave length corresponding to the absorption maximum of a component to be determined and ODM is the optical density at a wavelength where the same component does not absorb significantly.
The algorithm for dual wavelength measurement is by necessity more complex than for single wavelength measurement but is much more powerful. The first order correction applied by the 700 nm reading is a simple subtraction of background color due to blood. In order to make this correction, a relationship between absorbance at 635 nm and 700 nm due to blood color can be and was determined by measuring blood samples with 0 mg/dlglucose over a wide range of blood color. The color range was constructed by varying hemato crit, and fairly linear relationships were observed. From Note that the equivalence of the normalized 700 nm signal and the 635 nm signal is only true at zero glucose. The expressions from which the calibration curves were derived are defined by Equations 5 and 6.
These curves are best fit by fourth-order polynomial equations similar to Equation 3 to which a fourth-order term in K/S is added. The computer-fit coefficients for these equations are listed in Table 2 . The correction factors reported above were tailored to fit a single instrument and a limited number of rea gent preparations. The algorithm can be optimized for an individual instrument and reagent in the same man ner that is described above.
In summary, the system of the present invention mini mizes operator actions and provides numerous advan tages over prior art reflectance-reading methods. When compared to prior methods for determining glucose in blood, for example, there are several apparent advan tages. First, the amount of sample required to saturate the thin reagent pad is small (typically 5-10 microliters), and is of course, volume independent once the thresh old volume of blood is supplied to the reagent pad. Second, operator time required is only that necessary to apply the sample to the thin hydrophilic layer and close the cover (typically 4-7 seconds). Third, no simulta neous timing start is required. Fourth, whole blood can be used. The method does not require any separation or utilization of red-cell-free samples and likewise can be 65 used with other deeply colored samples. Fifth, via the reflectance reading and normalization techniques ap plied in the present invention the system provides reli Furthermore, the thin membranes used in the present invention would be expected When wet to transmit light and return only a weak signal to the reflectance measuring device. Prior teachings have generally indi cated that a reflective layer is necessary behind the matrix in order to reflect sufficient light. In other cases a white pad has been placed behind the reagent pad prior to color measurement. In the present case, neither a reflective layer nor a white pad is required. In fact, the invention is typically carried out with a light-absorbing surface behind the reagent element when incident light is impinged upon the matrix. This is accomplished using a light absorbing surface behind the reagent element, coupled with measuring reflectance at two different wavelengths. It allows acceptable reflectance measure ments to be obtained without removal of excess liquid from the matrix, thereby eliminating a step typically required by previous teachings.
The invention now being generally described, the same will be better understood by reference to the fol lowing specific examples which are presented for pur poses of illustration only and are not to be considered limiting of the invention unless so specified.
Example I Reproductibility: One male blood sample (having a hematocrit level of 45) was used to collect the reproducibility data using the presently preferred embodiment of the system, called the MPX system. The results are set forth in Tables 3-5.  TABLE 3 Reproducibility of a Single Wavelength System The blood was divided into aliquots and spiked with glucose across a range of 25-800 mg/dl. Twenty deter minations were made at each glucose test level from strips taken at random from a 500 strip sample (Lot FJ449B). The results of this study lead to the following Ing/dl the 30-second reading has a covariance of 2.1% and the 20-second result a covariance of 4.5%. As was seen in the K/S-20 response curve, the slope begins to decrease sharply above 250 mg/dl. This lead to poor reproducibility at glucose levels greater than 300 for the 20-second result. From this reproducibility data the cutoff for the 20-second result is somewhere between 100 and 326 mg/dl. A cutoff of 250 mg/dl was later deter mined from the results of the recovery study set forth in Example II.
3. Aperture Size: A smaller optics aperture size, 3.0 mm, was investigated. Initial experimentation using a 10 replicate, hand-dipped disk sample did show improved covariances with the 3.0 mm aperture, apparently because of easier registration with the system optics. However, when machine-made roll membrane was used, the average (Table 5) The blood samples were used within 30 hours of collec tion, with lithium heparin as the anti-coagulant. Each blood sample was divided into aliquots and spiked with glucose to give 152 samples in the range of 0-700 mg/dl glucose. Each sample was tested in duplicate for a total of 304 data points.
Response curves-were constructed for the appropri ate equation (see Tables 1 and 2 These scattergrams were quantitated by determining the deviations from YSI at various glucose ranges. The following results were obtained. In conclusion, the two MPX systems gave optimum quantitation in the 0-450 mg/dl range.
1. MPX System-30 Second Dual Wavelength: This dual wavelength system gave a 30-second measure ment time with a 95% confidence limit (defined as the probability of a measurement being within 2 Standard Deviation of the YSI reading) of 11.3% covariance for the range from 50-450 mg/dl (Table EXAMPLE III Stability Most of the bench-scale work carried out in optimiz ing stability was completed using hand-dipped 0.8. Posidyne TM membrane disks. The specific dye/en zyme formulation was set forth previously.
1. Room Temperature Stability: This study attempted to chart any change in response of the 0.8. Posidy neTM membrane reagent stored at 18 C-20 C. over silica gel desiccant. After 2.5 months there was no noticeable change as measured by the re sponse of a room temperature sample vs. the re sponse of a sample stored at 5 C. Each measure ment represented a glucose range of 0-450 mg/dl. 2. Stability at 37 C.: Stability study using the same reagent as the room temperature study was carried out. The differences in glucose values of reagent stressed at 37° C. vs. room temperature reagent, for strips stressed with and without adhesive, was plot ted over time. Although the data was noisy, due to the poor reproducibility of handmade strips, the stability was excellent for strips whether they were stressed with or without adhesive.
3. Stability at 56' C.: Eight 5-day to 6-day stability studies were carried out using different prepara tions of a similar formulation on disk membrane (Table 8 ). For the low glucose test level (80-100 mg/dl) the average glucose value dropped upon stressing by 3.4% with the highest drop being 9.55%. At the high test level (280-320 mg/dl) the glucose reading declined by an average of 3.4%, the largest decline being 10.0%. Average of 8 -3.4 -3-4 "These two samples contained twice the normal concentration of enzyme and dye.
A study of the 56° C. stressing of this membrane over a 19-day period showed no major difference for strips stressed with or without adhesive. In both cases the 19-day decline in glucose value was less than 15% at low test levels (80-100 mg/dl) and also at 300 mg/dl. Another 56°C. study using hand-dipped 0.8. Posidy neTM membrane with twice the normal concentration of enzyme and dye was completed. Two separate prepa rations of the same formulation were made up and the stability measured over a 14-day period. The average results of the two studies were compared. Changes were within +10% over the 14-day period at both the high and low glucose test level. Example IV Sample Size
The sample size requirements for the MPX System are demonstrated in Table 9 . The volumes reported in the table were transferred to the reagent pad 10 shown in FIG. 1 using a micropiper . When blood from a finger stick is applied to a strip the total sample cannot be transferred. Therefore, the vol umes reported here do not represent the total sample size needed to be squeezed from the finger for the analy sis. A 3 pull sample is the minimum necessary completely cover the reagent pad circle. This does not provide enough sample to completely saturate the reagent pad and the MPX System, whether single or dual wave length, gives low results. A4 pulsample barely saturates the reagent pad, while a 5ul sample is clearly adequate. A 10 pulsample is a large shiny drop and a 20 pull sample is a very large drop and is only likely to be used when blood from a pipet is used for sampling.
At the lower glucose concentration the single wave length result has some dependence on sample size, which is completely eliminated using the dual wave length measurement. Although this dependence with 5,426,032 23 the single wavelength might be considered acceptable, it is clearly undesirable.
Example V Reproducibility Experimental measurements described above were always run in replicate, usually 2, 3 or 4 determinations per data point. These sets have always shown close agreement even for samples with extreme hematocrits or extreme oxygen levels. covariances were well below 5%. It appears, therefore, that reproducibility is very good to excellent.
The subject invention provides for many commer cially or have been described in the literature. The protocols are simple and require little technical skill and are relatively free of operator error. The assays can be carried out rapidly. They use inexpensive and relatively harmless reagents, important considerations for materi als employed in the home. The user obtains results which can be understood and used in conjunction with maintenance therapy. In addition, the reagents have long shelf lives, so that the results obtained will be reli able for long periods of time. The equipment is simple and reliable and substantially automatic.
All patents and other publications specifically identi fied in this specification are indicative of the level of skill of those of ordinary skill in the art to which this invention pertains and are herein individually incorpo rated by reference to the same extent as would occur if each reference were specifically and individually incor porated by reference.
The invention now being fully described, it will be apparent to one of ordinary skill in the art that many modifications and changes can be made thereto without departing from the spirit or scope of the invention as defined in the following claims.
What is claimed is:
1. A whole blood glucose test strip for measuring glucose in an unmeasured whole blood sample which does not require removal of excess sample, said test strip being adapted for use in a reflectance reading apparatus which measures reflectance about 635 nm and about 700 nm, said test strip comprising: a porous, hydrophilic matrix, said matrix having a sample receiving surface adapted to receive said whole blood sample on one side of the matrix and a testing surface from which diffuse reflected light is measurable, said testing surface being opposite to said sample receiving surface, said matrix being substantially reflective in the absence of applied sample, said matrix containing openings of a size sufficient to allow the flow of at least a portion of said blood sample through the matrix from said sam ple receiving surface to said testing surface, said matrix comprising reagent means for chemical reacting with glucose to create a change in re flectance in the presence of optically visible he moglobin observable from the testing surface which change is indicative of the concentration of glucose present in said sample, said reagent means comprising glucose oxidase, peroxidase, and a dye precursor, said dye precursor comprising 3-dime thylaminobenzoic acid and 3-methyl-2-benzo thiazolinone hydrazone hydrochloride. 8. The test strip of claim 1 wherein said reagent means exhibits a pH of about 3.8 to 4.3.
9. The test strip of claim 1 wherein said reagent means exhibits a pH of about 4.
10. The test strip of claim 1 wherein said matrix com prises a membrane.
11. The test strip of claim 1 wherein said matrix com prises a microfiltration membrane.
12. The test strip of claim 1 wherein said matrix com prises a polyamide.
13. The test strip of claim 1 wherein said matrix com prises nylon.
14. The test strip of claim 13 wherein the surface of said matrix is positively charged.
15. The test strip of claim 14 wherein the surface of said matrix is functionalized with quaternary amine groups. 16. The test strip of claim 1 wherein said matrix com prises a microfiltration membrane made from nylon.
17. The test strip of claim 1 wherein said matrix com prises a microfiltration membrane made from nylon cast on a core of non-woven polyester fibers.
18. The test strip of claim 1 wherein the surface of said hydrophilic matrix is positively charged.
19. The test strip of claim 1 wherein said matrix is a single layer.
20. The test strip of claim 1 wherein said matrix has an average pore size of from about 0.2 to 2.0 urn.
21. The test strip of claim 1 wherein said matrix has an average pore size of from about 0.5 to 1.2 um.
22. The test strip of claim 1 wherein said matrix has an average pore size of about 0.882 m.
23. The test strip of claim 1 wherein said matrix con tains openings of a size sufficient to filter out red blood cells such that significant numbers of red blood cells do not reach said testing surface.
24. The test strip of claim 1 wherein said matrix is substantially uniformly reflective.
25. The test strip of claim 1 wherein the reflectance of said matrix is such that at least 50% of incident light is 27. The test strip of claim 1 where said hydrophilic matrix is accessible on both said sample receiving sur face and said testing surface.
28. 
